Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BiotricityBTCY -0.18%20 Days Payable is 491.06 as of Mar. 2026, which is 21% above its 10-year median of 406.17. GuruFocus rates BTCY with a GF Score™ of 20/100 and a GF Value™ of $0.39 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Biotricity ranks better than 93.58% on this metric.
Biotricity's average Accounts Payable for the
three
months ended in Mar. 2026 was $4.59 Mil. Biotricity's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $0.85 Mil.
Hence, Biotricity's Days Payable for the
three
months ended in Mar. 2026 was 491.06.
The historical rank and industry rank for Biotricity's Days Payable or its related term are showing as below:
BTCY'
s Days Payable Range Over the Past 10 Years
Min: 130.36 Med: 406.17 Max: 769.96
Current: 554.69
During the past 13 years, Biotricity's highest Days Payable was 769.96. The lowest was 130.36. And the median was 406.17.
BTCY's Days Payable is ranked better than 93.58% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs BTCY: 554.69
Biotricity's Days Payable
declined
from Mar. 2025 (581.23) to Mar. 2026 (491.06).
It may suggest that Biotricityaccelerated paying its suppliers.
Biotricity Days Payable Related Terms
Biotricity Days Payable Historical Data
* Premium members only.
The historical data trend for Biotricity's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Biotricity's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotricity Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biotricity's Days Payable distribution charts can be found below:
* The bar in red indicates where Biotricity's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Biotricity's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biotricity (BTCY) has a Days Payable of 491.06 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Biotricity and its competitors. This is 21% above median its historical median of 406.17. Over the past decade, Biotricity's Days Payable has ranged from 130.36 to 769.96. According to the industry distribution chart, Biotricity ranks #51 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 6.4%.
Is Biotricity's Days Payable too high?
Biotricity's current Days Payable of 491.06 is 21% above median its 10-year median of 406.17. Over the past 10 years, this metric has ranged from a low of 130.36 to a high of 769.96. The Medical Devices & Instruments industry median Days Payable is 67.97. Biotricity's value of 491.06 is 622.5% above this industry median. Based on the distribution chart, Biotricity ranks #51 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Biotricity has a GF Score™ of 20/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biotricity's Days Payable compare to FEED and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Biotricity ranks #51 out of 794 companies for Days Payable. This places Biotricity in the top 6% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.97. Biotricity's value of 491.06 is 622.5% above this benchmark. Historically, Biotricity's own Days Payable has ranged from 130.36 to 769.96 over the past decade. While the company's 10-year median is 406.17 vs. the industry median of 67.97, Biotricity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biotricity's current Days Payable of 491.06 is 622.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Biotricity and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biotricity's current Days Payable is 491.06, which is 21% above median its own 10-year median of 406.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotricity stock overvalued right now?
Based on GuruFocus' analysis, Biotricity (BTCY) is currently considered Possible Value Trap. The stock's GF Value™ is $0.39, compared to a current price of $0.11 — trading 71.1% below its estimated fair value. The current Days Payable is 491.06, which is 21% above median its 10-year median of 406.17 and 622.5% above the Medical Devices & Instruments industry median of 67.97. Biotricity's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Biotricity (BTCY), the current Days Payable is 491.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biotricity (BTCY) Overvalued in 2026?
Based on GuruFocus' analysis, Biotricity stock appears to be undervalued.
The current stock price of $0.11 is trading 71.1% below its estimated GF Value™ of $0.39.
GuruFocus considers Biotricity to be Possible Value Trap.
Key valuation signals for BTCY:
Days Payable: 491.06 (21% above median its 10-year median of 406.17)
GF Value™: $0.39 vs. price of $0.11 (71.1% below fair value)
Industry Position: 622.5% above the Medical Devices & Instruments median (#51 of 794)
No single metric tells the full story. See the BTCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.
20GF Score
Get the complete analysis for BTCY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BTCY has been successfully added to your 
